 |
|
Development of a Novel, Anti-idiotypic Monoclonal Anti-prolactin Antibody That Mimics the Physiological Functions of Prolactin
Meng Wang (Wang M), Dian-Cai Zhang (Zhang DC), Shen-Tian Wang (Wang ST), Ming-Long Li (Li ML)
Asian-Australas J Anim Sci. 2016;29(4):571-579. Published online 2016 Feb 24 DOI: https://doi.org/10.5713/ajas.15.0541
|
|
Citations to this article as recorded by
 Agonist antibody discovery: Experimental, computational, and rational engineering approaches
John S. Schardt, Harkamal S. Jhajj, Ryen L. O'Meara, Timon S. Lwo, Matthew D. Smith, Peter M. Tessier
Drug Discovery Today.2022; 27(1): 31. CrossRef Preparation of a Growth Hormone Receptor/Prolactin Receptor Bispecific Antibody Antagonist Which Exhibited Anti-Cancer Activity
Xin Chen, Di Wu, Yan Zheng, Xingxing Liu, Jianmeng Wang
Frontiers in Pharmacology.2020;[Epub] CrossRef Internal image anti-idiotypic antibody: A new strategy for the development a new category of prolactin receptor (PRLR) antagonist
Hainan Lan, Pan Hong, Ruonan Li, Suo L, Shan Anshan, Steven Li, Xin Zheng
Molecular Immunology.2017; 87: 86. CrossRef
|